Trilogy Capital Inc.

Position in AMGN — Amgen Inc

CIK 1722512 IRVINE, CA

Position in AMGN

as of Jun 30, 2026 · filed Jul 6, 2026 Compact

Position Value

$301,645

-$3,264,354 QoQ

Shares Held

833

-91.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#2,553

of 3,140 holders

Holding Since

Jun 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Trilogy Capital Inc. holds $25,279,882 across 7 Drug Manufacturers - General names. AMGN ranks #7 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	5,952	$7,139,007
2	ABBV	AbbVie Inc.	23,338	$5,872,774
3	GILD	Gilead Sciences, Inc.	41,026	$5,183,224
4	MRK	Merck & Co., Inc.	40,029	$5,143,726
5	JNJ	Johnson & Johnson	5,109	$1,297,532
6	BMY	Bristol Myers Squibb Co	5,935	$341,974
7	AMGN	Amgen Inc This page	833	$301,645

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$301,645	833	-91.8%	Shares	Sole	2026-07-06
2026-03-31	$3,565,999	10,135	-2.5%	Shares	Sole	2026-04-22
2025-12-31	$3,400,750	10,390	+0.9%	Shares	Sole	2026-01-22
2025-09-30	$2,904,966	10,294	-3.9%	Shares	Sole	2025-10-24
2025-06-30	$2,992,293	10,717	-2.6%	Shares	Sole	2025-07-18
2025-03-31	$3,427,673	11,002	+0.7%	Shares	Sole	2025-05-07
2024-12-31	$2,848,273	10,928	+8.8%	Shares	Sole	2025-01-27
2024-09-30	$3,235,632	10,042	-2.0%	Shares	Sole	2024-10-21
2024-06-30	$3,202,300	10,249	+3.3%	Shares	Sole	2024-07-23
2024-03-31	$2,820,454	9,920	+3.8%	Shares	Sole	2024-04-17
2023-12-31	$2,753,471	9,560	-6.5%	Shares	Sole	2024-01-12
2023-09-30	$2,748,071	10,225	+649.1%	Shares	Sole	2023-10-16
2021-12-31	$307,084	1,365	-7.5%	Shares	Sole	2022-01-18
2021-09-30	$313,658	1,475	+0.1%	Shares	Sole	2021-10-15
2021-06-30	$359,287	1,474	—	Shares	Sole	2021-07-14
No filing history on record for this holder in this stock.